Atazanavir Completed Phase 4 Trials for Human Immunodeficiency Virus (HIV) Infections / Human Immunodeficiency Virus Type 1 (HIV-1) Infection Treatment

IndicationsStatusPurposePhase
CompletedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT00082394A Study Comparing The Safety, Tolerability and Efficacy of Trizivir VS Combivir & Atazanavir In Subjects With HIV
NCT02246998Renal Effect of Stribild or Other Tenofovir DF-containing Regimens Compared to Ritonavir-boosted Atazanavir Plus Abacavir/Lamivudine in Antiretroviral Treatment-naive HIV-1 Infected Adults
NCT01351740Switch to Unboosted Atazanavir With Tenofovir Study
NCT01307488Simplification to Atazanavir/Ritonavir + Lamivudine as Maintenance Therapy
NCT01102972A Simplification Study of Unboosted Reyataz With Epzicom (ASSURE)
NCT00355719Study to Evaluate the Influence of Nevirapine to Atazanavir in Steady State Equilibrium in HIV Patients
NCT00084136Prospective Evaluation of Anti-retroviral Combinations for Treatment Naive, HIV Infected Persons in Resource-limited Settings
NCT00532168Once-daily Antiretroviral Therapy in HIV-1 Infected Patients With CD4+ Cell Counts Below 100 Cells/Mcl
NCT00552240Nevirapine vs. Atazanavir Boosted With Ritonavir on a Background of Truvada in Human Immunodeficiency Virus (HIV) Infected Naive Patients (NEwArT)
NCT00242216The Once A Day Protease Inhibitor Regimens
NCT00885482Atazanavir and Lamivudine for Treatment Simplification
NCT00207142Induction-Maintenance With Atazanavir in HIV Naïve Patients (The INDUMA Study)
NCT00224445Boosted Atazanavir and Truvada Given Once-Daily - BATON Study
NCT00762892Raltegravir vs. Atazanavir in Combination With Truvada® for the Treatment of Antiretroviral naïve HIV Infected Patients
NCT00756730Lopinavir/r or Fosamprenavir/r Switch to Atazanavir/r or Darunavir/r
NCT00544128Comparison of Epzicom and Truvada for the Initial Once Daily HIV Treatment
NCT00540137The CogNaive Study: Assessing Changes in Neurocognitive Function in Treatment Naïve HIV-1 Positive Subjects
NCT00084253Study of Boosted Atazanavir (ATV) Versus Non-boosted ATV in Naive Patients